Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Aptose Biosciences, Inc. (APTOF) had Return on Equity of 26.34% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-5.12M |
|
-- |
|
-- |
|
$4.91M |
|
$-4.91M |
|
$-0.21M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
$-4.91M |
|
$-4.80M |
|
2.55M |
|
2.55M |
|
$-2.01 |
|
$-2.01 |
|
| Balance Sheet Financials | |
$3.78M |
|
$0.01M |
|
$2.56M |
|
$6.34M |
|
$7.08M |
|
$18.71M |
|
$18.71M |
|
$25.79M |
|
$-19.45M |
|
$-19.45M |
|
$-19.45M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-16.15M |
|
-- |
|
$11.08M |
|
$6.71M |
|
$1.64M |
|
$-5.07M |
|
$0.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.53 |
|
-- |
|
-- |
|
-25.36 |
|
-0.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
26.34% |
26.34% |
|
-80.79% |
|
694.17% |
|
$-7.62 |
|
$-6.33 |
|
$-6.33 |
|